Aspergillus antigen latex test for diagnosis of invasive aspergillosis.

A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol (1995) 3.60

New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test. J Clin Microbiol (1993) 2.02

Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol (1995) 1.96

Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol (1995) 1.89

Typing of Aspergillus species and Aspergillus fumigatus isolates by interrepeat polymerase chain reaction. J Clin Microbiol (1993) 1.49

Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J Clin Pathol (1995) 1.36

Aspergillus antigen latex test for diagnosis of invasive aspergillosis. Lancet (1992) 1.20

Evaluation of PCR for detection of DNA specific for Aspergillus species in sera of patients with various forms of pulmonary aspergillosis. J Clin Microbiol (1998) 1.19

Use of the Pastorex aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis. J Clin Pathol (1995) 1.18

Aspergillus Fumigatus antigen detection in sera from patients at risk for invasive aspergillosis. J Clin Microbiol (2000) 1.03

Lack of utility of the lysis-centrifugation blood culture method for detection of fungemia in immunocompromised cancer patients. J Clin Microbiol (1998) 0.89

Enhanced differentiation of isolates of Candida albicans using a modified resistogram method. Mykosen (1982) 7.04

Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother (1997) 4.75

Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev (2001) 4.49

Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol (1988) 4.06

Fluconazole resistance in Candida glabrata. Lancet (1988) 4.05

Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother (1993) 4.04

BAX is required for neuronal death after trophic factor deprivation and during development. Neuron (1996) 4.02

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis (2001) 3.68

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother (1997) 3.40

Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell (1998) 3.25

Standardized susceptibility testing of fluconazole: an international collaborative study. Antimicrob Agents Chemother (1992) 3.19

Nature of lactose-fermenting Salmonella strains obtained from clinical sources. J Bacteriol (1969) 3.14

Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron (2001) 3.07

Resistogram method for differentiation of strains of Candida albicans. J Appl Bacteriol (1979) 2.97

Intergeneric bacterial matings. Bacteriol Rev (1968) 2.94

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol (2006) 2.86

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother (1995) 2.83

Vaginal candidiasis and the role of the digestive tract as a source of infection. Br J Obstet Gynaecol (1975) 2.76

In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemother (1997) 2.75

Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol (1994) 2.75

Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol (1993) 2.67

Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest (1998) 2.64

Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death. Neuron (1994) 2.54

Evidence of a novel event during neuronal death: development of competence-to-die in response to cytoplasmic cytochrome c. Neuron (1998) 2.49

In-vitro resistance to imidazole antifungals in Candida albicans. J Antimicrob Chemother (1984) 2.43

Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis (2000) 2.34

Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol (1994) 2.32

GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron (1998) 2.29

Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect (2003) 2.29

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol (2005) 2.29

Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother (1997) 2.27

Gene targeting reveals a critical role for neurturin in the development and maintenance of enteric, sensory, and parasympathetic neurons. Neuron (1999) 2.22

Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis. Antimicrob Agents Chemother (2000) 2.22

Genetic analysis of the ViA-his chromosomal region in Salmonella. J Bacteriol (1966) 2.17

Azole resistance in Candida albicans. J Med Vet Mycol (1986) 2.17

Characterization of transmissible genetic elements from sucrose-fermenting Salmonella strains. J Bacteriol (1975) 2.11

An initiation zone of chromosomal DNA replication located upstream of the c-myc gene in proliferating HeLa cells. Mol Cell Biol (1990) 2.08

Induction of nerve growth factor receptor in Schwann cells after axotomy. Proc Natl Acad Sci U S A (1986) 2.06

Material properties of commonly-used interface materials and their static coefficients of friction with skin and socks. J Rehabil Res Dev (1998) 2.04

Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther (1973) 2.04

Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J Virol (1987) 2.01

BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J Biol Chem (2001) 2.01

The HeLa Pur factor binds single-stranded DNA at a specific element conserved in gene flanking regions and origins of DNA replication. Mol Cell Biol (1992) 2.00

Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol (2009) 1.99

In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother (1998) 1.98

A laboratory comparison of T cell depletion by CD34+ cell immunoaffinity selection and in vitro Campath-1M treatment: clinical implications for bone marrow transplantation and donor leukocyte therapy. Bone Marrow Transplant (1997) 1.96

Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron (1995) 1.95

Typing of Candida albicans. J Hosp Infect (1984) 1.93

Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J Cell Biol (1997) 1.89

Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex. Neuron (1998) 1.89

Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet (1983) 1.88

The GDNF family ligands and receptors - implications for neural development. Curr Opin Neurobiol (2000) 1.88

RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons. Development (2001) 1.86

Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol (1999) 1.85

Pharmacokinetics of ketoconazole in normal subjects. J Antimicrob Chemother (1981) 1.84

Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature (1996) 1.83

Multicenter evaluation of Microring YT, a new method of yeast identification. J Clin Microbiol (1990) 1.83

Reversible changes in nucleosome structure and histone H3 accessibility in transcriptionally active and inactive states of rDNA chromatin. Cell (1983) 1.82

Detection of bacteraemia in patients with fever and neutropenia using 16S rRNA gene amplification by polymerase chain reaction. Eur J Clin Microbiol Infect Dis (1998) 1.78

Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother (2003) 1.75

Assay of typhoid vaccines with Salmonella typhosa-Salmonella typhimurium hybrids. Infect Immun (1973) 1.72

Computer-assisted rapid enzyme-linked immunosorbent assay (ELISA) in the serological diagnosis of aspergillosis. J Immunol Methods (1983) 1.70

Epidemiological investigation of patients with vulvovaginal candidosis. Application of a resistogram method for strain differentiation of Candida albicans. Br J Vener Dis (1979) 1.70

Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother (2001) 1.70

Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J Neurosci (1990) 1.69

A reevaluation of risk of in utero exposure to lithium. JAMA (1994) 1.68

Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse. Exp Neurol (1999) 1.67

Organic nitrates: relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther (1972) 1.67

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. Br J Haematol (1999) 1.66

Adenosine 3',5-monophosphate-dependent phosphorylation of a specific protein in synaptic membrane fractions from rat cerebrum. J Biol Chem (1972) 1.63

Toxic gas generation from plastic mattresses and sudden infant death syndrome. Lancet (1995) 1.60

An immunohistochemical study of the nerve growth factor receptor in developing rats. J Neurosci (1988) 1.59

In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother (2000) 1.59

Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J Cell Biol (1996) 1.59

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol (1997) 1.59

Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Dev Biol (1994) 1.59

BAX translocation is a critical event in neuronal apoptosis: regulation by neuroprotectants, BCL-2, and caspases. J Neurosci (1999) 1.59

Sulfhydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Ther (1973) 1.57

FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children. Med Pediatr Oncol (1999) 1.57

GFRalpha-mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival. Neuron (2000) 1.56

Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: ultrastructural location, suppression by axonal contact, and binding properties. J Neurosci (1988) 1.55

Neurturin and GDNF promote proliferation and survival of enteric neuron and glial progenitors in vitro. Dev Biol (1998) 1.55

Replication of a plasmid bearing a human Alu-family repeat in monkey COS-7 cells. Proc Natl Acad Sci U S A (1986) 1.54

Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein. Nucleic Acids Res (2000) 1.53

Sequence of cDNA comprising the human pur gene and sequence-specific single-stranded-DNA-binding properties of the encoded protein. Mol Cell Biol (1992) 1.53

Bioassays for itraconazole blood levels: an interlaboratory collaborative study. J Antimicrob Chemother (1999) 1.52

Evaluation of the AUXACOLOR system, a new method of clinical yeast identification. J Clin Pathol (1995) 1.51

Characterization and distribution of a maize cDNA encoding a peptide similar to the catalytic region of second messenger dependent protein kinases. Plant Physiol (1990) 1.51

Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology). BMJ (1995) 1.50

Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J Antimicrob Chemother (2000) 1.50

Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans. J Antimicrob Chemother (1998) 1.50